Phase I-II trial of high-dose epirubicin in patients with lymphoma.

Delvyn C. Case(Maine Medical Center), F. B. Oldham, Richard A. Gams(Breast Center), Thomas J. Ervin(Bayfront Medical Center), Marjorie A. Boyd

PubMed

December 1, 1987

Cited by 21

Related Papers

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

|New England Journal of Medicine|2013|6.6k

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

|New England Journal of Medicine|2007|1.7k

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2014|1.7k

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

|Journal of Clinical Oncology|1997|652

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

|International Journal of Radiation Oncology*Biology*Physics|1992|413